News

The Association of Clinical Research Professionals (ACRP) has learned that TransCelerate Biopharma, Inc., now recognizes certification through the Certified Clinical Research Coordinator (CCRC?) and Certified Physician Investigator (CPI?) programs of ACRP's affiliate, the Academy of Clinical Research Professionals (the Academy), as evidence of Good Clinical Practice (GCP) training.

Clinical research professionals who have a current CPI or CCRC designation will be able to use that as evidence that retaking GCP training is not necessary if they are working on a trial for one of the TransCelerate companies.

A recent report from the Business Monitor outlines India's strong commercial opportunities for pharmaceutical companies...

Global IT spending will increase at a cumulative annual growth rate (CAGR) of 3.6% to reach $40.8bn by 2017, predicts Ovum

ComprehensiveOffering Provides Flexible Access to Key Quality Processes

MediGuard App Wins Web Health Award

Business Monitor has just released its latest findings on India's pharmaceuticals and healthcare sector in its newly-published India Pharmaceuticals & Healthcare Report.

Sparta Systems announced that is offering mobile versions of selected TrackWise product suites.

MEDIAN Technologies announced that it has signed a contract with a San Francisco-area based biotech company

Eight million people in the US alone suffer from chronic stable angina, the chest pain and tightness associated with myocardial ischemia caused by coronary artery disease

FDA Purchases Novel ADDPLAN DF Software for Improved Evaluation of Phase II Dose-Finding Trials

Industry Leaders Share Expertise through Complimentary White Paper on ePRO Regulatory Inspections

IMS Health has filed a registration statement with the US Securities and Exchange Commission

IMS Health today announced that it has publicly filed a registration statement with the US Securities and Exchange Commission

Theorem Clinical Research has announced the formation of a strategic alliance with BioTelemetry, Inc.

With 2013 having come to a close and gearing up for a what's sure to be a fantastic 2014, it seems an appropriate time to reflect back on some of the most popular content of the year.

Significant Genotypic and Phenotypic Analytic Capabilities Added in New Release

CROS NT Ltd announced the acquisition of MDSL International

As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International

Employee turnover remains high in the US and is over 30 percent in some countries.

CRO Pay Incentives

Many of us concur that the biopharmaceutical industry is facing a crisis, and that the R&D process needs to transform entirely in order to address skyrocketing costs and minimal effectiveness.

CRO Employee Turnover

Employees at clinical research organizations (CROs) receive lower annual and long term incentives than their counterparts in other industries.

Drug companies can get more out of their CRO partners by treating them less like avatars and more like equals, according to conference-goers at a CBI event in The Triangle.

Our most read stories of 2013.

The disengagement of major drug firms is described as "a type of market failure" in a briefing paper published last month by the UK think-tank Chatham House.

EFPIA welcomes the agreement on the EU Clinical Trials Regulation concluded by the legislators today.